A Cleveland Clinic-led study shows that a specific type of diabetes drug can decrease the risk of cancer in female patients with type 2 diabetes by up to 32 percent.People with type 2 diabetes have a higher rate of cancer development and recurrence compared to the general population. This study - published online by the journal Diabetes, Obesity and Metabolism - shows that widely prescribed anti-diabetes drugs can be linked to either an increased or decreased risk of cancer, depending on the type of medication prescribed.A team of researchers led by Sangeeta Kashyap, M.D.
No comments:
Post a Comment